Intranasal Delivery of Octreotide · Diabetic Macular Edema
Withdrawn before enrolling
Also in this update: Primary completion date changed from estimate of Dec 2027 to Oct 8, 2026
University of Alabama at BirminghamPhase 1 NCT06881888 Registry history of NCT06881888 on ClinicalTrials.gov (opens the registry)